The value of deprescribing in older adults with dementia: a narrative review
| Autor: | Kristina Johnell, Danijela Gnjidic, Joanna C Ng, Megan J Ma, Mouna J Sawan, Daniela C. Moga |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Gerontology
Drug-Related Side Effects and Adverse Reactions Population Psychological intervention Inappropriate Prescribing Deprescriptions Outcome Assessment Health Care Medicine Dementia Humans Pharmacology (medical) General Pharmacology Toxicology and Pharmaceutics education Aged Polypharmacy education.field_of_study business.industry General Medicine medicine.disease Discontinuation Clinical trial Research Design Narrative review Deprescribing business |
| Zdroj: | Expert review of clinical pharmacology. 14(11) |
| ISSN: | 1751-2441 |
| Popis: | Introduction:Mitigating the burden of unnecessary polypharmacy or multiple medication use in people living with dementia has been recognized as a key priority internationally. One approach to reducing inappropriate polypharmacy is through medication withdrawal or deprescribing.Area covered:Non-systematic searches of key databases including PubMed, Embase, and Google Scholar were conducted from inception to 28 February 2021 for articles that assessed the safety and/or efficacy of deprescribing in older adults living with dementia. Personal reference libraries were also utilized. Information on current clinical trials was found in clinicaltrial.gov.Expert Opinion: There is limited direct evidence to inform deprescribing in older adults with dementia specifically. This review identified nineteen studies that have assessed the impact of deprescribing interventions to reduce inappropriate polypharmacy or direct deprescribing of specific medications. However, the current evidence is limited in scope as most studies focused on medication-related outcomes (e.g. discontinuation of high-risk medications) rather than patient-centered outcomes in individuals living with dementia. Furthermore, most studies focused on addressing inappropriate polypharmacy in older adults with dementia living in long-term care facilities, and interventions did not involve the person and their carer. Further evidence on the impact of deprescribing in this population across clinical settings is needed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|